Amneal Pharmaceuticals's total assets for Q2 2025 were $3.42B, an increase of 1.71% from the previous quarter. AMRX total liabilities were $2.36B for the fiscal quarter, a -31.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.